BIOCRYST PHARMACEUTICALS INC (BCRX) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $1.21 | +381.4% |
| 2024 | $-0.43 | +63.6% |
| 2023 | $-1.18 | +11.3% |
| 2022 | $-1.33 | -29.1% |
| 2021 | $-1.03 | +5.5% |
| 2020 | $-1.09 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $1.21 | +381.4% |
| 2024 | $-0.43 | +63.6% |
| 2023 | $-1.18 | +11.3% |
| 2022 | $-1.33 | -29.1% |
| 2021 | $-1.03 | +5.5% |
| 2020 | $-1.09 | — |